Please assess the completion status of the following clinical trial:

Trial Title: Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients suffering from moderate to severe dry eye syndrome for 6 months or more after conventional treatments with artificial tears following LASIK.~* Tear break-up time (TBUT) between 4 and 9 seconds.~Exclusion Criteria:~* Ocular pathology needing topical treatments different than dry eye syndrome~* Trombocitopeny, associated pathologies to coagulation factors or any state of plaquets antiagregation (AAS and other AINES).~* Ocular tumours, corneal distrophies, history of ocular herpes.~* Pregnant or nursering women.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).